Work

Research data warehouse best practices: catalyzing national data sharing through informatics innovation

Year: 2022

Type: article

Abstract: Research Patient Data Repositories (RPDRs) have become essential infrastructure for traditional Clinical and Translational Science Award (CTSA) programs and increasingly for a wide range of research consortia and learning health system networks.1–5 Almost every institution with a CTSA or Clinical Translational Research (CTR) program (found in states with lower amounts of National Institutes of Health funding) hosts an RPDR for the benefit of affiliated researchers. These repositories aim to enable healthcare research based upon the patient populations they serve. Within the institution, RPDRs are valuable for a range of research activities. They are used to identify patients for clinical trial recruitment using privacy-preserving methods to search and extract specific cohorts of trial-eligible patients.6 They aid in developing and validating computable phenotypes that are increasingly important for accurately identifying patient cohorts in a reproducible fashion.7 RPDRs provide de-identified patient data for population health research and support a growing body of artificial intelligence to predict patient outcomes.8 Further, clinical studies can often be simulated using data from an RPDR.9 Beyond the institution, aggregates of de-identified datasets from multiple institutions linked with privacy-preserving hash codes provide an unprecedented opportunity to conduct population health research, perform comparative effectiveness analyses and apply artificial intelligence methods over large and diverse populations.10 The data contained within the RPDR vary across institutions, based on institutional strengths and weaknesses; the papers published in this issue reflect that variability (see Table 1). Data are commonly acquired from local electronic health records (EHRs) and other clinical information systems that capture information during clinical care. Data consist of diagnoses, problem lists, procedures, prescribed medications, laboratory exams, and many types of free-text reports. Overall, the benefits of the RPDR for accelerating translational research can be significant. For example, at Harvard, in 2006, between $94 and $136 million in annual research funding was linked to the use of data from the RPDR.11

Source: Journal of the American Medical Informatics Association

DOI: 10.1093/jamia/ocac024